Loperamide N-oxide
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Loperamide N-oxide Product Information
Loperamide N-oxide is listed under Metabolite and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Loperamide. The product is supplied by Clearsynth under CAT No. CS-O-06077.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Loperamide N-oxide
CAS No.
106900-12-3
CAT No.
CS-O-06077
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C29H33ClN2O3
Molecular Weight
493.04
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Loperamide N-oxide is supplied with detailed characterization data compliant with regulatory guideline. Loperamide N-oxide can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Loperamide.
Overview
Loperamide oxide (LOPOX) is a prodrug of Loperamide (LOP). It is concluded that Loperamide oxide administered intraluminally is reduced to Loperamide and has the same antisecretory potency as Loperamide in jejunum and colon.
Synonyms
Loperamide N-oxide
Application Notes
Loperamide oxide (LOPOX) is a prodrug of Loperamide (LOP). It is concluded that Loperamide oxide administered intraluminally is reduced to Loperamide and has the same antisecretory potency as Loperamide in jejunum and colon.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.